CTLA4 and atherosclerosis: To investigate the effects of immune checkpoint inhibition on atherosclerosis in more detail, we treated 12-week-old Ldlr–/– mice on a 0.15% cholesterol diet twice a week with anti-CTLA4 and anti-PD1 antibodies for 5 weeks (Figure 2A).